SB883Introduced in the Senate
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Introduced by Angela Paxton, District 8
What does this bill do?
Plain-English breakdown
Writing a plain-English summary of this bill… this can take a few seconds the first time.
Official description
Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.
Where it stands
Referred to Public Health
April 22, 2025
How did lawmakers vote?
SenateStage: Read 3rd time · April 10, 2025
0
Yes
0
No
0
Absent or Not Voting
0 senators recorded in this Senate vote. Colors show vote categories only, not whether a vote was good or bad.
What do people think?
Citizen Voice
How would you vote on this bill?
An unofficial public opinion poll. It does not affect the bill or the official vote.
One response per device. Location is self-reported and not verified. Results are informal and not a scientific survey.
See how each senator voted
| Senator | District | Vote |
|---|
Bill history
Received by the Secretary of the Senate
Filed
Read first time
Referred to Health & Human Services
Co-author authorized
Scheduled for public hearing on . . .
Considered in public hearing
Testimony taken in committee
Left pending in committee
Considered in public hearing
Vote taken in committee
Reported favorably w/o amendments
Committee report printed and distributed
Placed on intent calendar
Co-author authorized
Rules suspended-Regular order of business
Record vote
Read 2nd time & passed to engrossment
Record vote
Rules suspended-Regular order of business
Record vote
Read 3rd time
Passed
Record vote
Reported engrossed
Received from the Senate
Read first time
Referred to Public Health
Verify the information
Our commitment to neutrality
We provide factual information only. We never tell you which politicians or bills to support, and we do not rank, score, or endorse anyone.